<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02839018</url>
  </required_header>
  <id_info>
    <org_study_id>NAChO</org_study_id>
    <nct_id>NCT02839018</nct_id>
  </id_info>
  <brief_title>Nutrient Pattern Analysis in Critically Ill Patients (NAChO)</brief_title>
  <acronym>NAChO</acronym>
  <official_title>Nutrient Pattern Analysis in Critically Ill Patients Using Omics Technology (NAChO): A Prospective Single-center Observational Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Inselspital, Berne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Nestec Ltd.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital Inselspital, Berne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Little is known about nutritional Parameters that potentially influence the course of&#xD;
      intensive-care unit acquired weakness (ICU - AW). The investigators aim to elucidate the&#xD;
      nutritional profiles in blood, urine and muscle in respective patients at risk.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 2017</start_date>
  <completion_date type="Actual">March 20, 2020</completion_date>
  <primary_completion_date type="Actual">January 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Differences in blood nutrient levels over time in patients with/without ICU-AW (i.e. &quot;ICU-AW group&quot; vs. &quot;no-ICU-AW group&quot;. Primary comparison of interest is between day 14 vs. day 6.</measure>
    <time_frame>days 6 to 14</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Differences in blood nutrient levels over time in patients in &quot;sepsis group&quot; vs. &quot;CNS group&quot;. Primary comparison of interest is between day 14 vs. day 6.</measure>
    <time_frame>days 6 to 14</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Differences in urine nutrient levels over time in patients with/ without ICU-AW (i.e. &quot;ICU-AW group&quot; vs. &quot;no-ICU-AW group&quot;. Primary comparison of interest is between day 14 vs. day 6.</measure>
    <time_frame>days 6 to 14</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Differences in urine nutrient levels over time in patients in &quot;sepsis group&quot; vs. &quot;CNS group&quot;. Primary comparison of interest is between day 14 vs. day 6.</measure>
    <time_frame>days 6 to 14</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subgroup analysis: differences in nutrient levels at day 14 vs. day 6 in muscle biopsy samples of ICU long stayer patients in study groups (i.e. &quot;ICU-AW&quot; vs. &quot;no-ICU-AW&quot; and &quot;Sepsis&quot; vs. &quot;CNS&quot;).</measure>
    <time_frame>days 6 to 14</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">100</enrollment>
  <condition>Intensive Care Unit (ICU) Acquired Weakness (ICU - AW)</condition>
  <condition>Muscle Weakness</condition>
  <arm_group>
    <arm_group_label>Central nervous system (CNS) group</arm_group_label>
    <description>n=50 patients with presumed low prevalence of ICU-AW</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Severe sepsis/shock group</arm_group_label>
    <description>n=50 patients with presumed high prevalence of ICU-AW</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood, Urine, Muscle biopsy&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        critically ill patients with severe Sepsis/shock (&quot;Sepsis Group&quot;) or intracerebral&#xD;
        conditions (CNS Group)&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age ≥18 years&#xD;
&#xD;
          -  Written informed consent obtained from the patient's legal representative and later&#xD;
             from the patients (as soon as possible)&#xD;
&#xD;
          -  Individuals diagnosed with severe head trauma or intracerebral hemorrhage (&quot;central&#xD;
             nervous system group&quot;) or with severe sepsis/ septic shock (&quot;Sepsis group&quot;) at any&#xD;
             time from ICU admission until day 5 (i.e. day of screening)&#xD;
&#xD;
          -  Patient on the ICU for ≥ 5 days (&quot;ICU long stayer&quot;)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Language other than German or French&#xD;
&#xD;
          -  Institutionalized Individuals (e.g. prisoners, severe pre-existing mental incapacity)&#xD;
&#xD;
          -  Patients with known pre-existing neurological or psychiatric disease that will make&#xD;
             informed consent likely impossible&#xD;
&#xD;
          -  Patients with known pregnancy or known to be lactating will not be included to the&#xD;
             investigation. Due to the observational/ diagnostical nature of the study, a pregnancy&#xD;
             test will not be performed.&#xD;
&#xD;
          -  Patients on extracorporeal membrane oxygenation (ECMO)&#xD;
&#xD;
          -  Clinical signs of pre-existing malnutrition (Body mass index &lt;18)&#xD;
&#xD;
          -  Pre-existing evidence for history of anorexia or bulimia&#xD;
&#xD;
          -  Parenteral nutrition received within last 5 days (for more than 12 hours) or evidence&#xD;
             for parental nutrition needed within next 7 days&#xD;
&#xD;
          -  Terminal disease (i.e. life expectancy &lt;14 days)&#xD;
&#xD;
          -  Patients with active malignancy&#xD;
&#xD;
          -  Patients on biologicals interfering with metabolism (e.g. infliximab)&#xD;
&#xD;
          -  Patients on chronic steroid medication (i.e. prednisone equivalent dose &gt;10mg/day)&#xD;
&#xD;
          -  Patients on neuromuscular blocking agents on a regular basis (i.e. on a repetitive&#xD;
             basis within last 48 hours or evidence for need within next 7 days)&#xD;
&#xD;
          -  At screening (day 5): prescribed caloric intake substantially higher (i.e. &gt; 150% of&#xD;
             caloric need of indirect calorimetry) than indirect calorimetric results (in intubated&#xD;
             patients) or i.e. standard-of-care (25 Kcal/kg body weight/day)&#xD;
&#xD;
          -  Severe adipositas defined as BMI &gt;40&#xD;
&#xD;
          -  Known pre-existing allergy to standard enteral formulae&#xD;
&#xD;
          -  Subject previously enrolled to an interventional trial that is not considered&#xD;
             standard-of-care (e.g. investigation of new medication/drug or medical devices)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joerg C Schefold, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Inselspital, Bern University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jukka Takala, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Inselspital, Bern University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Stephan M Jakob, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Inselspital, Bern University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Inselspital, Dept of Intensive Care Medicine</name>
      <address>
        <city>Bern</city>
        <zip>3010</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>July 18, 2016</study_first_submitted>
  <study_first_submitted_qc>July 19, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 20, 2016</study_first_posted>
  <last_update_submitted>March 20, 2020</last_update_submitted>
  <last_update_submitted_qc>March 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Muscle Weakness</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

